CorAssist Cardiovascular Ltd.

corassist.com

Formerly Relaxis

High-Tech Company

Suspended Operations Q2/2022

Graduated from: Abital

TECH VERTICALS

Healthtech, Heart Failure, Life Sciences, Machine Vision, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2001
Number of Employees	6
Reg. Number:	abCDe

DESCRIPTION

CorAssist is a clinical stage medical device company developing innovative therapeutic products for treating Heart failure with preserve ejection fraction. The company's proprietary technology enables the first implantation of devices that directly improves cardiac diastolic function.

TECHNOLOGY

The company's product, the CORolla®, is an elastic self-expanding internal spring-like device implanted inside the left ventricular, through a Transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance and does not require an external power source.

Products and Phases

Product	Phase
CORolla	Phase I
The CORolla is an elastic device implanted inside the left ventricle in Trans apical approach or percutaneous procedure. The device applies direct internal expansion forces distributed on the left ventricle wall and the septum to improve diastolic function.
ImCardia	Phase I
The ImCardia is an elastic self-expanding device that is attached to the external left ventricle surface of the heart through a simple off-pump procedure. It applies an outward expansion force on the ventricular wall to improve diastolic function.

	TARGET MARKETS
	Cardiac Surgeons, Cardiologists

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Haifa, Israel

Address	57 Derech Haatzmaut St.
POB	33066
City	Haifa
Country	Israel
Zip	3303329

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Shay Dubi	Co-Founder	XT Venture Capital (VP)
Dr. Yair Feld	Co-Founder	Vital View (Technical & Business Advisor)
Dr. Yotam Reisner	Co-Founder	Nephera (VP, Clinical Affairs)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Co-Founder, CorAssist

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Venture Lending

Jan. 01, 2019

R&D

abCDe

Third Round

Feb. 01, 2012

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Institutional Investor	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe

Second Round

Mar. 17, 2009

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe	Led the round
abC Defghij	Investment Company	abCDe

First Round

Jun. 01, 2005

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed - Extended

Jul. 19, 2004

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed

Oct. 01, 2003

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Sep. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

R&D Grant

Oct. 01, 2003

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe